BRONCUS-B (02216) grants 2,695,500 awards.
Broncus-B (02216) announced that on October 15, 2026, the Company granted 2,695,500 awards to 6 grantees under the terms of the restricted share unit plan (representing the same number of underlying shares and approximately 0.51% of the total number of issued shares as at the date of this announcement), subject to acceptance.
BRONCUS-B (02216) announced that on October 15, 2026, the Company granted 2,695,500 awards to 6 grantees under the terms of the restricted share unit plan (representing the same number of underlying shares and approximately 0.51% of the total number of issued shares as of the date of this announcement), subject to acceptance.
Related Articles
AI + Automotive Dual Engines Driving Growth! StoneX Initiates onsemi (ON.US) with a "Buy" Rating, Stock Price Could Rise Another 50%
KAFELAKU COFFEE (01869): Zhu Haoqin has been appointed as an independent non-executive director.
Beijing Hotgen Biotech Co.,Ltd(688068.SH) subsidiary SGC001 innovative drug "expected severe acute pancreatitis" indication Phase II clinical study completed first subject enrollment and dosing
AI + Automotive Dual Engines Driving Growth! StoneX Initiates onsemi (ON.US) with a "Buy" Rating, Stock Price Could Rise Another 50%
KAFELAKU COFFEE (01869): Zhu Haoqin has been appointed as an independent non-executive director.
Beijing Hotgen Biotech Co.,Ltd(688068.SH) subsidiary SGC001 innovative drug "expected severe acute pancreatitis" indication Phase II clinical study completed first subject enrollment and dosing
